Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval save search
Viveve Announces FDA Approval to Conduct PURSUIT Trial for Improvement of Stress Urinary Incontinence
Published: 2020-07-07 (Crawled : 19:10) - ir.viveve.com
VIVE | $0.0002 59900.0% 1.4K
|
Health Technology
| Email alert
Add to watchlist
fda approval fda trial approval
Greenrose Acquisition Corp. Stockholders Approve Business Combination
Published: 2021-10-27 (Crawled : 23:00) - globenewswire.com
GNRS 4 | $0.001 33900.0% 110K
|
Finance
|
| O: 2.97%
H: 0.96%
C: -2.4%
acquisition acquisition corp approval
Empower Clinics Kai Medical Laboratory Becomes Approved Vaccine Provider
Published: 2021-11-08 (Crawled : 23:00) - empowerclinics.com
EPWCF | $0.0001 33700.0% 250
|
Health Services
|
| O: -0.33%
H: 0.73%
C: -2.17%
vaccine approval
Tailwind Acquisition Corp. and NUBURU, Inc. Announce Stockholder Approval of Business Combination – Marketscreener.com
Published: 2022-12-27 (Crawled : 15:00) - spacfeed.com
KKR | $92.62 -0.78% 0.0% 4.5M
|
Finance
|
| O: -0.77%
H: 0.19%
C: -1.33%
acquisition approval
COVID-19 Nucleic Acid Amplification Tests (NAATs) Medical Devices Pipeline Market Report 2021: Analysis by Stage of Development, Territory, Regulatory Path, Estimated Approval Date, Clinical Trials
Published: 2022-02-11 (Crawled : 21:00) - prnewswire.com
GWHP | $0.0001 4000.0% 86K
|
Mining, Quarrying, and Oil and ...
| Email alert
Add to watchlist
PMCB | $2.2 0.0% 11K
|
Manufacturing
| Email alert
Add to watchlist
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
| Email alert
Add to watchlist
covid-19 als ces trials device trial approval covid clinical trials report test
LMP Automotive Holdings, Inc. Receives General Motors’ Manufacturer Approval for Certain of its Subsidiaries as it Relates to its Stage 1 Southeast Acquisitions
Published: 2020-12-23 (Crawled : 21:02) - globenewswire.com
LMPX | $0.1055 1200.0% 300
|
Technology Services
|
| O: -0.63%
H: 0.7%
C: -7.72%
acquisition acquisitions approval
LMP Automotive Holdings, Inc. Announces Board Approval for Debt Refinancing and Conditional Approval of a Stock Buy Back and Dividend
Published: 2021-07-08 (Crawled : 21:00) - globenewswire.com
LMPX | $0.1055 1200.0% 300
|
Technology Services
|
| O: 14.98%
H: 0.0%
C: 0.0%
approval
Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell Lymphom
Published: 2023-01-17 (Crawled : 11:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: -8.26%
H: 14.0%
C: 10.0%
td011 treatment t-cell trial approval therapeutics
Acer Therapeutics and Relief Therapeutics Announce U.S. FDA Approval of OLPRUVA™ for Patients with Urea Cycle Disorders
Published: 2022-12-27 (Crawled : 14:00) - globenewswire.com
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: 3.33%
H: 12.26%
C: 8.06%
RLFTY | $1.4006 733.33% 100
|
n/a
|
| O: 2.37%
H: 0.0%
C: 0.0%
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: -3.23%
H: 0.28%
C: -31.11%
urea fda approval therapeutics
Relief Therapeutics Announces IRB Approval and Initiation of an Investigator Initiated Trial of Nexodyn for Epidermolysis Bullosa at Ann & Robert H. Lurie Children's Hospital of Chicago
Published: 2022-09-22 (Crawled : 07:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: -20.21%
H: 40.17%
C: 33.19%
trial approval therapeutics initiated
Relief Therapeutics Announces Swissmedic Approval and Operation of New Good Manufacturing Practice-Compliant Laboratory
Published: 2023-05-15 (Crawled : 10:00) - biospace.com/
RLFTY | $1.4006 733.33% 100
|
n/a
| Email alert
Add to watchlist
RLFTF | $1.43 11.45% 3.8K
|
n/a
| Email alert
Add to watchlist
approval therapeutics
NuRAN Announces SITE LIVE IN DRC, APPROVAL OF CAMEROON BANK LOAN AND CHANGE OF YEAR END
Published: 2021-11-29 (Crawled : 14:00) - nuranwireless.com
FRBA | $12.66 4.46% 4.27% 57K
|
Finance
|
| O: -2.82%
H: 0.93%
C: -1.67%
approval
FINRA Announces Approval for Corporate Name Change From China Infrastructure Construction Corp. to Cannabis Bioscience International Holdings and Ticker Symbol Change from CHNC to CBIH
Published: 2023-08-21 (Crawled : 13:00) - globenewswire.com
CHNC | $0.0004 575.0% 860K
|
n/a
| Email alert
Add to watchlist
cannabis change approval construction bioscience international china
Bioxytran Receives Approval to Initiate Trials with ProLectin-I
Published: 2023-02-06 (Crawled : 16:00) - biospace.com/
BIXT A | $0.1285 490.75% 32K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 3.09%
C: -2.06%
trials approval
Bioxytran Receives Approval to Optimize Dosage in COVID-19 Patients
Published: 2022-12-08 (Crawled : 13:20) - biospace.com/
BIXT A | $0.1285 490.75% 32K
|
Professional, Scientific, and T...
|
| O: 4.78%
H: 0.0%
C: 0.0%
covid-19 approval
Collective Metals Receives Approval to Re-log and Sample 2014 Drill Core from its Princeton Project
Published: 2023-10-04 (Crawled : 11:00) - globenewswire.com
GCFFF | $0.015 483.33% 47K
|
Non-Energy Minerals
| Email alert
Add to watchlist
approval
Nova Mentis Receives Health Canada Approval for First-Of-Its-Kind Psilocybin Clinical Trial
Published: 2022-12-22 (Crawled : 20:00) - biospace.com/
NMLSF | $0.0091 400.0% 1.1K
|
n/a
|
| O: 13.67%
H: 14.69%
C: 4.34%
canada health trial approval psilocybin
Nova Mentis Receives Institutional Review Board Approval to Commence Psilocybin Clinical Trial
Published: 2023-04-11 (Crawled : 15:00) - biospace.com/
NMLSF | $0.0091 400.0% 1.1K
|
n/a
|
| O: 2.16%
H: 0.0%
C: -0.53%
approval review trial psilocybin
Mallinckrodt Receives Approval to List on NYSE American
Published: 2022-10-24 (Crawled : 12:00) - biospace.com/
MNKPF | $17.25
|
n/a
| Email alert
Add to watchlist
MNKKQ | $0.02
|
Manufacturing
| Email alert
Add to watchlist
MNK | $0.3402 -0.06% 540K
|
n/a
| Email alert
Add to watchlist
approval
Mallinckrodt Receives U.S. FDA Approval for Terlivaz® (terlipressin) for injection for the Treatment of Hepatorenal Syndrome (HRS)
Published: 2022-09-15 (Crawled : 03:00) - prnewswire.com
MNKPF | $17.25
|
n/a
|
| O: 10.71%
H: 16.13%
C: 15.81%
terlivaz treatment fda approval injection
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.